HSPD1 and nasopharyngeal carcinoma: Furthermore, PQR309 sensitized NPC to gemcitabine by increasing caspase-dependent pathway apoptosis, blocking GSK-3β and STAT3/HSP60 signaling pathways, and inhibiting EMT (Fig. 7).